PIM
UTHR icon

Plato Investment Management’s United Therapeutics UTHR Stock Holding History

Plato Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$635K Buy
1,179
+7
+0.6% +$3.94K 0.04% 337
2026
Q1 		$695K Hold
1,172
– – 0.05% 313
2025
Q4 		$574K Sell
1,172
-94
-7% -$43.8K 0.04% 334
2025
Q3 		$527K Sell
1,266
-520
-29% -$175K 0.04% 337
2025
Q2 		$511K Hold
1,786
– – 0.04% 344
2025
Q1 		$557K Sell
1,786
-163
-8% -$55.9K 0.05% 320
2024
Q4 		$690K Sell
1,949
-645
-25% -$237K 0.05% 307
2024
Q3 		$929K Sell
2,594
-1,414
-35% -$478K 0.08% 253
2024
Q2 		$1.28M Buy
4,008
+264
+7% +$69.9K 0.12% 177
2024
Q1 		$860K Buy
+3,744
New +$845K 0.09% 219

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Plato Investment Management's UTHR Position: Q2 2026 in Review

Plato Investment Management increased its United Therapeutics (UTHR) stake by 0.6% in Q2 2026, buying an estimated $3.94K and bringing the position to 1,179 shares worth $635K. The position accounts for 0.04% of the portfolio, ranked #337.

Plato Investment Management first reported a position in UTHR in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.28M in Q2 2024. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Plato Investment Management held 1,179 shares of United Therapeutics worth $635K as of Q2 2026.
  • Plato Investment Management bought 7 United Therapeutics shares in Q2 2026, an estimated $3.94K.
  • United Therapeutics made up 0.04% of Plato Investment Management's portfolio in Q2 2026, its #337 holding.
  • Plato Investment Management first reported a position in United Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Plato Investment Management's United Therapeutics position peaked at $1.28M in Q2 2024.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.